This content is machine translated Dupilumab EU approval for severe chronic rhinosinusitis with polyposis nasi The monoclonal antibody dupilumab, which has already been approved by the European Medicines Agency (EMA) for the treatment of atopic dermatitis and asthma, is now also available for patients with…
View Post 3 min This content is machine translated Benign prostatic hyperplasia Inhibition of inflammation as a central mechanism of action Sage palmetto fruit and nettle root extract has been repeatedly shown to be effective for the treatment of benign prostatic hyperplasia. Recent studies have focused on the anti-inflammatory properties of…
View Post 3 min This content is machine translated Risankizumab as a therapeutic option “Real life” interim balance: PASI 100 – realistic target Risankizumab has been approved in Switzerland since April 2019 for moderate to severe plaque psoriasis after unsuccessful therapy with conventional systemic treatment. The high and long-lasting efficacy with rapid response…
View Post 1 min This content is machine translated Sunscreen for sensitive skin Mineral face sunscreen with “anti-aging” effect Combining infrared A protection and elimination of potentially harmful ingredients, these reformulated SPF50+ products launched three years ago stand out.
View Post 3 min This content is machine translated Breast Cancer BRCA mutations and their consequences Breast carcinoma is the most common malignant tumor of the mammary gland. In particular, mutations of the BRCA genes significantly increase the risk of disease, which is why genetic testing…
View Post 2 min This content is machine translated Breathing gas measurement for asthmatics First FeNO meter for home measurement Bosch Healthcare Solutions has developed the world’s first patient device for FeNO measurement. It is intended to give asthma patients more security in everyday life. The meter was launched on…
View Post 1 min This content is machine translated Squamous cell carcinoma Pembrolizumab as first-line therapy reduces mortality rate In a phase III trial, pembrolizumab improved overall survival in patients with recurrent or metastatic head and neck squamous cell carcinoma.
View Post 2 min This content is machine translated Eosinophilic asthma Mepolizumab now also available as pen and prefilled syringe At the beginning of August 2019, GSK received approval from the EMA for two new dosage forms of mepolizumab: The IL-5 antibody can now also be administered as a pen…
View Post 6 min This content is machine translated Hawthorn extract What are the pharmacological bases of the cardioprotective effects? The empirically proven positive effects of hawthorn extract range from vasodilation and endothelial modulation to influencing cholesterol metabolism and other cardiovascular-relevant parameters. This article highlights the underlying biochemical mechanisms of…
View Post 2 min This content is machine translated Multiple sclerosis Improve quality of life, inhibit disease progression Not only the quality of life, but also mobility and inhibition of progression in multiple sclerosis can be sustainably increased thanks to the latest therapeutic approaches. Immunomodulatory drugs have already…
View Post 3 min This content is machine translated Chronic inflammatory skin diseases Positive long-term effects in moderate to severe psoriasis Recently published data from the multicenter LIBERATE study confirm the favorable benefit-risk profile of apremilast with long-term use. This is a significant advance for the treatment options of this patient…
